Catalytic Wealth Ria, LLC Novo Nordisk A S Transaction History
Catalytic Wealth Ria, LLC
- $569 Billion
- Q4 2024
A detailed history of Catalytic Wealth Ria, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 14,992 shares of NVO stock, worth $1.36 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
14,992
Previous 15,689
4.44%
Holding current value
$1.36 Million
Previous $1.87 Billion
30.97%
% of portfolio
0.23%
Previous 0.33%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,884Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.81 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.4 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.18 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.15 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.11 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $205B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...